Curi RMB Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$748K	Sell	13,242 -695	-5%	-$40.5K	0.01%	506
2025 Q4	$828K	Buy	+13,937	New	+$759K	0.01%	496
2023 Q3	–	Sell	-3,540	Closed	-$307K	–	500
2023 Q2	$307K	Hold	3,540	–	–	0.01%	431
2023 Q1	$344K	Hold	3,540	–	–	0.01%	411
2022 Q4	$366K	Buy	3,540 +140	+4%	+$13.1K	0.01%	395
2022 Q3	$288K	Hold	3,400	–	–	0.01%	409
2022 Q2	$282K	Hold	3,400	–	–	0.01%	417
2022 Q1	$262K	Hold	3,400	–	–	0.01%	405
2021 Q4	$300K	Hold	3,400	–	–	0.01%	402
2021 Q3	$263K	Hold	3,400	–	–	0.01%	409
2021 Q2	$284K	Hold	3,400	–	–	0.01%	418
2021 Q1	$257K	Hold	3,400	–	–	0.01%	415
2020 Q4	$298K	Hold	3,400	–	–	0.01%	499
2020 Q3	$259K	Sell	3,400 -738	-18%	-$74.7K	0.01%	522
2020 Q2	$510K	Buy	4,138 +738	+22%	+$73.3K	0.02%	402
2020 Q1	$287K	Sell	3,400 -14	-0.4%	-$1.21K	0.01%	499
2019 Q4	$289K	Hold	3,414	–	–	0.01%	562
2019 Q3	$230K	Sell	3,414 -283	-8%	-$21.8K	0.01%	641
2019 Q2	$317K	Hold	3,697	–	–	0.01%	621
2019 Q1	$328K	Buy	3,697 +148	+4%	+$13.7K	0.01%	654
2018 Q4	$302K	Sell	3,549 -200	-5%	-$19K	0.01%	743
2018 Q3	$364K	Sell	3,749 -2	-0.1%	-$200	0.01%	689
2018 Q2	$353K	Buy	3,751 +202	+6%	+$17.7K	0.01%	687
2018 Q1	$288K	Buy	3,549 +60	+2%	+$5.15K	0.01%	739
2017 Q4	$311K	Buy	+3,489	New	+$303K	0.01%	708
2017 Q2	–	Sell	-6,300	Closed	-$553K	–	726
2017 Q1	$553K	Buy	+6,300	New	+$560K	0.03%	361